EATON VANCE MANAGEMENT - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 179 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$593,000
+13.6%
8,004
-0.0%
0.00%0.0%
Q2 2022$522,000
-11.7%
8,007
-14.4%
0.00%0.0%
Q1 2022$591,000
+14.3%
9,351
-4.2%
0.00%0.0%
Q4 2021$517,000
-15.1%
9,756
+4.6%
0.00%0.0%
Q3 2021$609,000
-97.7%
9,323
-97.7%
0.00%
-97.2%
Q2 2021$26,602,000
-76.9%
399,184
-61.5%
0.04%
-78.8%
Q1 2021$114,957,000
-49.4%
1,035,553
-45.9%
0.17%
-5.6%
Q4 2020$227,300,000
+142.9%
1,914,110
+78.4%
0.18%
+4.7%
Q3 2020$93,591,000
+11.6%
1,072,669
+14.6%
0.17%
+1.2%
Q2 2020$83,831,000
+45.0%
936,026
+61.4%
0.17%
+20.6%
Q1 2020$57,807,000
+91.6%
580,011
+120.9%
0.14%
+139.0%
Q4 2019$30,166,000
+10.4%
262,551
+21.2%
0.06%0.0%
Q3 2019$27,323,000
+11.4%
216,606
+6.2%
0.06%
+9.3%
Q2 2019$24,534,000
+86.9%
203,875
+35.9%
0.05%
+80.0%
Q1 2019$13,127,000
+2830.1%
150,056
+3254.0%
0.03%
+2900.0%
Q4 2018$448,000
-12.7%
4,4740.0%0.00%0.0%
Q3 2018$513,000
+23.6%
4,474
-3.2%
0.00%0.0%
Q2 2018$415,000
-38.4%
4,623
-49.8%
0.00%0.0%
Q1 2018$674,000
+152.4%
9,216
+100.7%
0.00%0.0%
Q4 2017$267,000
+30.2%
4,593
+0.6%
0.00%0.0%
Q3 2017$205,000
-54.7%
4,564
-59.5%
0.00%0.0%
Q4 2016$453,000
-35.7%
11,281
-42.0%
0.00%
-50.0%
Q3 2016$704,000
+246.8%
19,446
+329.7%
0.00%
+100.0%
Q1 2015$203,0004,5260.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders